Kenneth Krogulski - Net Worth and Insider Trading

Kenneth Krogulski Net Worth

The estimated net worth of Kenneth Krogulski is at least $360,721 dollars as of 2024-04-27. Kenneth Krogulski is the Director of Cumberland Pharmaceuticals Inc and owns about 204,955 shares of Cumberland Pharmaceuticals Inc (CPIX) stock worth over $360,721. Details can be seen in Kenneth Krogulski's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kenneth Krogulski has not made any transactions after 2022-12-21 and currently still holds the listed stock(s).

Transaction Summary of Kenneth Krogulski

To

Kenneth Krogulski Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kenneth Krogulski owns 1 companies in total, including Cumberland Pharmaceuticals Inc (CPIX) .

Click here to see the complete history of Kenneth Krogulski’s form 4 insider trades.

Insider Ownership Summary of Kenneth Krogulski

Ticker Comapny Transaction Date Type of Owner
CPIX Cumberland Pharmaceuticals Inc 2022-12-21 director

Kenneth Krogulski Latest Holdings Summary

Kenneth Krogulski currently owns a total of 1 stock. Kenneth Krogulski owns 204,955 shares of Cumberland Pharmaceuticals Inc (CPIX) as of December 21, 2022, with a value of $360,721.

Latest Holdings of Kenneth Krogulski

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPIX Cumberland Pharmaceuticals Inc 2022-12-21 204,955 1.76 360,721

Holding Weightings of Kenneth Krogulski


Kenneth Krogulski Form 4 Trading Tracker

According to the SEC Form 4 filings, Kenneth Krogulski has made a total of 18 transactions in Cumberland Pharmaceuticals Inc (CPIX) over the past 5 years, including 18 buys and 0 sells. The most-recent trade in Cumberland Pharmaceuticals Inc is the acquisition of 3,050 shares on December 21, 2022, which cost Kenneth Krogulski around $6,771.

Insider Trading History of Kenneth Krogulski

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kenneth Krogulski Trading Performance

GuruFocus tracks the stock performance after each of Kenneth Krogulski's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth Krogulski is 2.04%. GuruFocus also compares Kenneth Krogulski's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth Krogulski within 3 months outperforms 9 times out of 21 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kenneth Krogulski's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kenneth Krogulski

Average Return

-28.11%

Average return per transaction

Outperforming Transactions

5%

1 out of 21 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.21 2.04 -13.74 -28.11 -24.77 -24.04
Relative Return to S&P 500(%) -3.93 0.33 -13.46 -30.84 -34.34 -33.07

Kenneth Krogulski Ownership Network

Ownership Network List of Kenneth Krogulski

No Data

Ownership Network Relation of Kenneth Krogulski


Kenneth Krogulski Owned Company Details

What does Cumberland Pharmaceuticals Inc do?

Who are the key executives at Cumberland Pharmaceuticals Inc?

Kenneth Krogulski is the director of Cumberland Pharmaceuticals Inc. Other key executives at Cumberland Pharmaceuticals Inc include Vice Pres Sales & Marketing Chris T. Bitterman , Vice Pres Organizational Dev Todd M. Anthony , and director & 10 percent owner & Chairman and CEO A J Kazimi .

Cumberland Pharmaceuticals Inc (CPIX) Insider Trades Summary

Over the past 18 months, Kenneth Krogulski made 3 insider transaction in Cumberland Pharmaceuticals Inc (CPIX) with a net purchase of 7,880. Other recent insider transactions involving Cumberland Pharmaceuticals Inc (CPIX) include a net purchase of 4,540 shares made by Joseph C Galante , a net purchase of 2,093 shares made by James Jones , and a net purchase of 1,299 shares made by Caroline Young .

In summary, during the past 3 months, insiders sold 0 shares of Cumberland Pharmaceuticals Inc (CPIX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cumberland Pharmaceuticals Inc (CPIX) were sold and 15,812 shares were bought by its insiders, resulting in a net purchase of 15,812 shares.

Cumberland Pharmaceuticals Inc (CPIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cumberland Pharmaceuticals Inc Insider Transactions

No Available Data

Kenneth Krogulski Mailing Address

Above is the net worth, insider trading, and ownership report for Kenneth Krogulski. You might contact Kenneth Krogulski via mailing address: 2525 West End Avenue, Suite 950, Nashville Tn 37203.

Discussions on Kenneth Krogulski

No discussions yet.